Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytek Biosciences Inc
(NQ:
CTKB
)
5.090
-0.200 (-3.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cytek Biosciences Inc
< Previous
1
2
Next >
Cytek Biosciences Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
July 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
May 31, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Announces $50 Million Stock Repurchase Program
May 19, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports First Quarter 2023 Financial Results
May 09, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
April 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces New 20-Color AML Panel
March 07, 2023
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 07, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 06, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
November 21, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces Cytek Cloud
November 15, 2022
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research – from Panel Design to Data Acquisition
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Third Quarter 2022 Financial Results
November 09, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
October 26, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.